Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125192551 | 12519255 | 1 | I | 201512 | 20160125 | 20160701 | 20160701 | PER | DE-LUPIN PHARMACEUTICALS INC.-E2B_00004822 | LUPIN | 43.00 | YR | M | Y | 116.00000 | KG | 20160624 | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125192551 | 12519255 | 1 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | Y | UNKNOWN | 78103 | 80 | MG | |||||||
| 125192551 | 12519255 | 2 | SS | Atorvastatin | ATORVASTATIN | 1 | Oral | Y | UNKNOWN | 0 | 40 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125192551 | 12519255 | 1 | Hypercholesterolaemia |
| 125192551 | 12519255 | 2 | Hypercholesterolaemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125192551 | 12519255 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125192551 | 12519255 | Blood creatine phosphokinase increased | |
| 125192551 | 12519255 | Myalgia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125192551 | 12519255 | 1 | 201509 | 201511 | 0 | |
| 125192551 | 12519255 | 2 | 201512 | 201601 | 0 |